Andrew E. Arai, M.D., F.A.H.A. joined the National Heart, Lung, and Blood Institute (NHLBI) in 1993. He is Chief of the Advanced Cardiovascular Imaging Laboratory in the Institute's Division of Intramural Research. Dr. Arai is also Past President of the Society for Cardiovascular Magnetic Resonance. Dr. Arai’s research focuses on coronary artery disease, heart attack, and other diseases that affect the heart or blood vessels. His expertise is in the use of cardiac magnetic resonance imaging (CMR) to evaluate patients.
Gadobutrol enhanced CMR to detect significant coronary artery disease defined by quantitative coronary angiography. Results from two blinded phase III clinical trials
Event: ESC Congress 2019
Topic: Stress Cardiac Magnetic Resonance (CMR)
Session: Innovations in CMR imaging of coronary artery disease
